Abstract Mesenchymal Stromal Cells (MSCs) offer tremendous potential for the treatment of
various diseases and their healing properties have been explored in hundreds of clinical …

Human adipose-derived mesenchymal stromal cells (ASC) are showing clinical promise for
the treatment of a range of inflammatory and degenerative conditions. These lipoaspirate …

Summary 2018 was the year of the first marketing authorization of an allogeneic stem cell
therapy by the European Medicines Agency. The authorization concerns the use of …

Adipose tissue is a rich, ubiquitous and easily accessible source for multipotent stromal/stem
cells and has, therefore, several advantages compared to other sources of mesenchymal …

2018 was the year of the first marketing authorization of an allogeneic stem cell therapy by
the European Medicines Agency. The authorization concerns the use of allogeneic adipose …

Significance: Wound healing is a complex process involving pain and inflammation, where
innervation plays a central role. Managing wound healing and pain remains an important …

Compared with bone marrow-derived mesenchymal stem cells, adipose tissue-derived
stromal cells (ADSC) do have an equal potential to differentiate into cells and tissues of …

Improving the effectiveness of adipose‐tissue derived human mesenchymal stromal/stem
cells (AMSCs) for skeletal therapies requires a detailed characterization of mechanisms …

Human mesenchymal stromal cells, whether from the bone marrow or adipose tissue
(hASCs), are promising cell therapy agents. However, generation of abundant cells for …

The osteogenic and chondrogenic differentiation ability of adipose-derived mesenchymal
stromal cells (ASCs) and their potential therapeutic applications in bone and cartilage …